The Evolving Role of Combined Modality Therapy in Head and Neck Cancer

t is a privilege and an honor to address the members of the American Head and Neck So- ciety and our guests. To my knowledge, this organization represents the largest group of individuals in the world whose primary mission is dedicated to promoting education and research on head and neck cancer. This past year, an inaugural year, has been a major step forward for head and neck surgeons in this country. We have restructured; we have accommo- dated important goals from each of the 2 merging societies; and, most importantly, we have been able to work together to build an infrastructure that will serve us well for the future. I am indebted to my copresident, Ashok Shaha, with whom it has been an absolute pleasure to interact. He is a man who is sensitive to those around him, as well as a great team player. I would also like to ac- knowledge the council, especially cosecretaries Jonas Johnson and Bill Farrar, cotreasurers Ernie Weymuller and John O'Brien, and President-Elect Jesus Medina, who have performed their re- sponsibilities diligently, have provided wisdom and guidance, and, most importantly, have shown respect for each other and our new system of governance. Robin Wagner, who does all the work behind the scenes, deserves a special thanks. Finally, I would like to acknowledge Gayle Wood- son, my wife, colleague, and best friend, for her support, encouragement, and confidence.